Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis
Clinical trial NCT00832585 · COMPLETED
Trial details
- NCT number
- NCT00832585
- Sponsor
- Rush University Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2009-09-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.